Biotage AB (OSTO:BIOT) Other Long-Term Liabilities : kr200 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Biotage AB Other Long-Term Liabilities?

Biotage AB's other long-term liabilities for the quarter that ended in Mar. 2024 was kr200 Mil.

Biotage AB's quarterly other long-term liabilities increased from Sep. 2023 (kr206 Mil) to Dec. 2023 (kr343 Mil) but then declined from Dec. 2023 (kr343 Mil) to Mar. 2024 (kr200 Mil).

Biotage AB's annual other long-term liabilities declined from Dec. 2021 (kr128 Mil) to Dec. 2022 (kr93 Mil) but then increased from Dec. 2022 (kr93 Mil) to Dec. 2023 (kr343 Mil).

Biotage AB Other Long-Term Liabilities Historical Data

The historical data trend for Biotage AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Other Long-Term Liabilities Chart

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Biotage AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Biotage AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Biotage AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biotage AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (OSTO:BIOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OSTO:BIOT) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.